2-cyanopyrimidin-4-yl carbamate or urea derivative or salt thereof, and pharmaceutical composition including same

A compound of Formula 1 or pharmaceutically acceptable salt thereof:

• wherein,
• A is a bond, —CH2—, —O—, or —C(CH3)2—,
• L is —(CH2)m—O—, —(CH2)n—NH—, —CH(CH3)—NH—, or —N(CH3)—,
• m is 1 or 2,
• n is 0, 1, or 2,
• Ar is an aromatic ring selected from the group consisting of phenyl, phenoxy-phenyl, pyridinyl-phenyl, indazolyl-phenyl, morpholinyl-phenyl, piperazinyl-phenyl, piperidinyl-phenyl, pyrazolyl-phenyl, benzyl-phenyl, phenylaminophenyl, biphenyl, piperazinyl-biphenyl, morpholinyl-biphenyl, naphthyl, benzodioxolyl, furanyl, indazolyl, quinoxalinyl, and indanyl, and
• the aromatic ring is optionally substituted with one to three substituents selected from the group consisting of halogen, cyano, hydroxy, trifluoromethyl, C1˜C4 alkyl, C3˜C6 cycloalkyl, C1˜C4 alkoxy, hydroxy-C1˜C4 alkyl, C1˜C4 alkoxy-C1˜C4 alkyl, hydroxycarbonyl-C1˜C4 alkyl, C1˜C4 alkoxycarbonyl-C1˜C4 alkyl, C1˜C4 alkoxy-C1˜C4 alkoxy-C1˜C4 alkyl, C1˜C4 alkylcarbonylamino-C1˜C4 alkyl, amino-C1˜C4 alkoxy, mono- or di-C1˜C4 alkylamino-C1˜C4 alkoxy, aminosulfonyl, C1˜C4 alkyl-sulfonyl, trifluoromethylsulfonyl, C3˜C6 cycloalkylaminosulfonyl, mono- or di-C1˜C4 alkylamino, C1˜C4 alkylcarbonylamino, methanesulfonylamino, C1˜C4 alkylcarbonyl, hydroxycarbonyl, mono- or di-C1˜C4 alkylaminocarbonyl, oxolanyl-C1˜C4 alkylaminocarbonyl, di-C1˜C4 alkylamino-C1˜C4 alkylaminocarbonyl, imidazolyl-C1˜C4 alkylaminocarbonyl, C1˜C4 alkoxy-C1˜C4 alkylaminocarbonyl, C3˜C6 cycloalkylaminocarbonyl, pyrrolidinylcarbonyl, triazolyl-C1˜C4 alkylaminocarbonyl, C1˜C4 alkoxycarbonyl-C2˜C4 alkynyl, hydroxycarbonyl-C2˜C4 alkynyl, hydroxy-C1˜C4 alkylphenyl-C2˜C4 alkynyl, and C1˜C4 alkoxy-C1˜C4 alkyl-phenoxymethyl.